MANH — —
Loading…
— —
PREV CLOSE — OPEN — DAY RANGE —
Analyzing 0%
MASTER — —
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—
ESEN Ranks Forecast News Intelligence Fundamentals ESEN Deep Analysis Screener
ESEN Output Unavailable — MANH

Generated: 2026-09-29T23:04:17Z

> build_news_intel failed: BadRequestError

> Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'Your credit balance is too low to access the Anthropic API. Please go to Plans & Billing to upgrade or purchase credits.'}, 'request_id': 'req_011CfYZppuaa85JtKzb7eEH4'}

SNAPSHOT
Ticker
MANH
Company
Manhattan Associates
Sector
Technology
Market Cap
$11.7B
Current Price
$196.50
52W High / Low
$220.72 / $119.06
YTD Return
−8.75%
Beta
0.93
EARNINGS MOMENTUM

Last 4 quarters EPS & revenue trajectory

Metric Current / TTM YoY Change Status
EPS (TTM) $3.49 −2.60% Declining
Revenue Growth (YoY) 6.48% Moderate Positive
Forward P/E 32.75x Compressed Elevated
Trailing P/E 53.26x High Premium

Analysis: Revenue growth of 6.48% YoY shows resilience in the core software/supply chain optimization business. However, EPS contracted 2.6% YoY despite topline growth, signaling margin compression or increased cost burden. The substantial gap between trailing P/E (53.3x) and forward P/E (32.7x) implies market is pricing in material earnings recovery ahead—a bold assumption given current trajectory.

📊 Earnings Momentum Score: 4/10 | Direction: CAUTIONARY | Mixed signals—revenue positive but EPS declining; forward guidance premium suggests recovery bet with limited confirmation.
PROFITABILITY & QUALITY

Margin structure and cash generation health

Metric Value Assessment
Gross Margin Data not disclosed Coverage gap
Operating Margin Data not disclosed Coverage gap
Net Margin Data not disclosed Coverage gap
Free Cash Flow (TTM) Data not disclosed Coverage gap
ROE / ROIC Data not disclosed Coverage gap

Analysis: Detailed profitability and cash flow metrics are not currently available through primary sources. However, the presence of flags for "high valuation" and "hyper growth" (despite negative EPS growth YoY) suggests the market is pricing MANH as a growth story rather than a current cash-generation powerhouse. The "strong profitability" flag is marked FALSE, indicating concerns around current margin health or return-on-capital efficiency.

💰 Quality Score: 3/10 | Verdict: CONSTRAINED VISIBILITY | Unable to independently verify profitability quality due to limited financial disclosure. Market flags suggest weak current profitability relative to valuation; growth narrative dominates.
BALANCE SHEET HEALTH

Leverage, liquidity, and solvency position

Metric Value Assessment
Cash & Equivalents Data not disclosed Coverage gap
Total Debt Data not disclosed Coverage gap
Net Debt / EBITDA Data not disclosed Coverage gap
Current Ratio Data not disclosed Coverage gap
Weak Balance Flag FALSE No red flag

Analysis: Balance sheet detail is not available through current sources. However, the absence of a "weak balance" flag in system metrics suggests no immediate solvency or liquidity crisis. Beta of 0.93 (below market) implies lower leverage risk relative to sector, though this is inferential. Recommend obtaining latest 10-Q/10-K for detailed debt structure and covenant positions.

🏦 Balance Sheet Risk: MODERATE | No red flags detected, but limited visibility. Likely stable given tech sector positioning and absence of distress signals; recommend direct review of debt schedule and liquidity facilities.
VALUATION ANALYSIS

Absolute and relative valuation metrics

Multiple MANH Interpretation
Trailing P/E 53.26x Extreme premium
Forward P/E 32.75x High premium
PEG Ratio −20.49 Negative (EPS declining)
EV / Enterprise Value $11.7B Implies large-cap premium valuation
Price / Sales Data not disclosed Unable to calculate
Price / FCF Data not disclosed Unable to calculate

Analysis: MANH trades at a significant valuation premium: trailing P/E of 53.3x is extreme for a company with negative EPS growth. The 32.7x forward P/E implies the market is discounting a sharp earnings acceleration—likely 40%+ EPS growth over next 12–24 months. The negative PEG (−20.49) confirms this: with EPS declining, the valuation is divorced from fundamentals. High valuation flag is confirmed. Without comparables, cannot assess sector positioning, but these multiples are characteristic of "story stocks" expecting multi-year transformations.

💸 Valuation Status: OVERVALUED | Forward P/E 32.75x on declining EPS is richly priced for execution risk. Trailing 53.3x is unjustifiable without material near-term recovery. Risk/reward asymmetric to downside unless earnings inflect sharply.
ANALYST TARGETS & SENTIMENT

Consensus view and price targets

Metric Value Status
Consensus Rating Data not disclosed Coverage gap
Avg. Price Target Data not disclosed Coverage gap
High / Low Targets Data not disclosed Coverage gap
Implied Upside/Downside Data not disclosed Coverage gap
Target Dispersion Data not disclosed Coverage gap

Analysis: Analyst consensus and price targets are not available through current sources. The data gap limits visibility into Wall Street sentiment shift. However, the 52-week performance (−8.75% YTD, down from $220.72 high) and recent −2.2% daily decline suggest sentiment may have soured post-earnings or macro shift. Recommend checking Bloomberg, Refinitiv, or company filings for latest institutional positioning.

📈 Wall Street Sentiment: UNKNOWN | Limited visibility on analyst consensus. Price action (down 8.75% YTD from 52W high) suggests recent disappointment; recommend direct check of latest broker reports.
INSTITUTIONAL & RISK CHECK

Ownership, insider activity, and red flags

Risk Factor Status Severity
Institutional Ownership Trend Data not disclosed Coverage gap
Insider Buying / Selling Data not disclosed Coverage gap
Short Interest Data not disclosed Coverage gap
High Valuation Flag TRUE Active
Hyper-Growth Flag TRUE Active
Strong Profitability Flag FALSE Warning
Weak Balance Flag FALSE Clear

Analysis: System flags reveal core risk structure: MANH is tagged as "high valuation" + "hyper-growth" + "NOT strong profitability." This combination is dangerous—the stock is priced for aggressive growth but not delivering current profitability to justify the premium. Weak balance flag is absent, so balance sheet is not a near-term threat. However, the growth thesis is unproven (6.48% revenue growth is modest; EPS declining). Insider activity and short interest unknown but should be monitored as proxy for confidence levels.

⚠️ Risk Level: HIGH | Valuation/growth mismatch is primary concern. Stock priced for multi-year transformation but delivering modest revenue growth and negative EPS momentum. Execution risk is acute; any guidance miss or macro headwind could trigger significant repricing.
ESEN FINAL VERDICT
39
Overall Fundamental Score
Conviction Level: MODERATE-NEGATIVE
Evidence base is incomplete due to data gaps, but available metrics paint a cautionary picture: premium valuation (P/E 53.3x trailing, 32.7x forward) combined with declining EPS growth and undisclosed profitability metrics creates significant execution risk. The "growth story" requires material earnings acceleration not yet visible in fundamentals.
Short Term
1–3 Months
HOLD / REDUCE
Medium Term
6–12 Months
CAUTIOUS
Long Term
2+ Years
DEPENDS ON INFLECTION
Summary — 5 Key Points
✗ Valuation Disconnect: Trailing P/E 53.3x and forward P/E 32.75x on declining EPS (−2.6% YoY) imply market is pricing perfection—material earnings recovery required to justify premium.
✗ Earnings Deceleration: While revenue grows 6.48% YoY, EPS contracted, signaling margin compression or increased OpEx burden not yet explained.
⚠ Profitability Opacity: Detailed margin and return-on-capital metrics unavailable; system flags indicate "strong profitability" = FALSE, raising questions about true cash-generation power.
✓ Balance Sheet Stable: No weak balance flag; beta 0.93 suggests moderate leverage; solvency not an immediate threat.
⚠ Execution Risk HIGH: Stock is a "story bet"—requires near-term earnings inflection and guidance raise to justify valuation. Any miss triggers repricing. Recommend waiting for Q3 earnings confirmation or entry on 15–20% pullback.

MANH Stock AI Analysis

ESEN AI analysis of MANH stock updated every 12 hours.

AI STOCK INSIGHT

MANH Stock Analysis & Forecast

Is MANH a Good Investment in 2026?

Our model indicates a neutral outlook based on current fundamentals and momentum.

MANH Stock Forecast

Based on recent earnings trends, valuation metrics, and sector performance, MANH shows balanced risk-reward characteristics.

Should You Buy MANH Now?

Investors should consider market conditions, volatility, and long-term positioning before taking a position in MANH.

Related Stocks
AAPL NVDA MSFT AMZN GOOGL META TSLA AVGO JPM V MA LLY UNH XOM JNJ WMT PG HD MRK COST BAC ABBV CRM CVX ORCL KO PEP AMD NFLX ADBE

Explore AI analysis for top stocks — Full Rankings · AI Screener · Earnings Calendar